Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

Delayed Data
As of Dec 12
 +0.08 / +0.41%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 19.50, with a high estimate of 33.00 and a low estimate of 8.00. The median estimate represents a -0.36% decrease from the last price of 19.57.

Analyst Recommendations

The current consensus among 10 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 2,768.60%
Growthannually 132.62%


Growthquarterly 134.36%
Growthannually 99.49%
Key to the earnings and sales forecast charts.